136.86
+3.94%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About ZIM Laboratories
Its shares trade on NSE under the ticker ZIMLAB.NS. It has been listed since 8 June 2018. In the fiscal year to 31 March 2026, it reported revenue of ₹3.69bn and net income of ₹58.4m. At that date it held total assets of ₹5.39bn and shareholders' equity of ₹2.96bn.
Zim Laboratories Ltd. is a pharmaceutical company. The company is headquartered in Nagpur, Maharashtra. The company went IPO on 2018-06-08. The firm develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. The company is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 8 Jun 2018
- Employees
- 525
- Website
- zimlab.in ↗
Leadership
Pay as last reported
- Dr. Anwar DaudExecutive Chairman of the Board, Managing Director₹12.0m
- Mr. Shyam PatroChief Financial Officer
- Mr. Zulfiquar KamalDirector - Finance, Executive Director₹8.3m
- Mr. Piyush NikhadeCompliance Officer, Company Secretary
- Mr. Niraj DhadiwalWhole - Time Director, since 2025₹7.5m
- Mr. Prakash SapkalWhole - Time Director, since 2025₹7.4m
- Dr. Ashok BhatiaAdditional Independent Director
- Mr. Padmakar JoshiNon-Executive Independent Director₹100,000
- Mrs. Kavita LoyaNon-Executive Independent Director₹600,000
- Dr. Kamlesh ShendeNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Zim Laboratories Ltd employs 525 full-time employees in Nagpur, Maharashtra.
- The company develops and manufactures oral solid generic pharmaceutical formulations in multiple therapeutic segments.
- Zim Laboratories offers technological capabilities in drug release modification and solubility enhancement.
Weaknesses
- Zim Laboratories Ltd has an IPO listing date of 8 June 2018.
- The company focuses on oral solid differentiated generic pharmaceutical formulations only.
- Zim Laboratories Ltd is headquartered in Nagpur, Maharashtra, India.
Opportunities
- Zim Laboratories develops products in central nervous system and anti-biotic therapeutic segments.
- The company's technological capabilities include taste masking and dosage form transformation.
- Zim Laboratories offers finished formulations and pre-formulation intermediates like granules and tablets.
Threats
- Zim Laboratories Ltd operates in the Health Care sector with a focus on Pharmaceuticals.
- The company's product offerings include oral thin films and dry suspensions.
- Zim Laboratories Ltd is listed on the stock market since 8 June 2018.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.